IL37 and atherosclerosis: Recombinant IL- (rIL-) 37 has been shown to alleviate mouse atherosclerosis and myocardial infarction by inhibiting cardiomyocyte apoptosis, a finding that asserts that IL-37 is inextricably linked to cardiovascular disease [9–11].